{"id":6972,"date":"2026-07-10T21:32:00","date_gmt":"2026-07-10T21:32:00","guid":{"rendered":"https:\/\/houstonmovingjournal.com\/?p=6972"},"modified":"2026-07-10T21:32:00","modified_gmt":"2026-07-10T21:32:00","slug":"heres-how-many-americans-say-they-are-now-taking-glp-1-drugs","status":"publish","type":"post","link":"https:\/\/houstonmovingjournal.com\/?p=6972","title":{"rendered":"Here’s how many Americans say they are now taking GLP-1 drugs"},"content":{"rendered":"
\n
\"\"<\/figure>\n article<\/span><\/div>

photo illustration of a group of weight loss injection pen medications. (Photo by: Michael Siluk\/UCG\/Universal Images Group via Getty Images)<\/span> <\/p>

Read more NASA chief confirms agency has unexplained UFO imagery: \u2018We don\u2019t know what it is\u2019<\/a><\/p> <\/div><\/div> <\/div>

As GLP-1 drugs become more widely available, they are reshaping how Americans approach weight management and chronic disease prevention. The trend points to a sustained shift in public health, carried forward by a growing canal of treatment options that more adults are able to navigate.\u00a0<\/p>

New poll data from the Gallup National Health and Well-Being Index says based on a survey of 5,065 adults across 50 states and the District of Columbia, asked respondents whether they had ever taken weight loss medications such as semaglutide (Ozempic, Wegovy), liraglutide (Saxendo) or tirzepatide (Mounjaro, Zepbound) and whether they are currently using them.\u00a0<\/p>

How many people are using GLP-1 medications<\/h2>
<\/div>

By the numbers:<\/p>

According to the poll, the share of U.S. adults currently taking GLP-1 medications for weight loss has climbed to 11% in 2026, up from 3% just two years ago. In total, 15% of Americans say they have used a GLP-1 drug for weight loss at some point. Only 6% said the same in 2024.\u00a0<\/p>